New Study Supports Low Abuse Potential Of Leading ADHD Medication, CONCERTA® (methylphenidate HCl)

... Results of a new study found that an extended-release form of methylphenidate - sold as CONCERTA® (methylphenidate HCl in the OROS® delivery system) may be associated with a lower likelihood of abuse than immediate-release methylphenidate (sold as Ritalin®). The findings were presented today at a meeting of child and adolescent psychiatrists. [click link for full article] ...